Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 23, Issue 1-2, Pages 97-104
http://dx.doi.org/10.1155/2007/159242

MGMT Methylation Status: The Advent of Stratified Therapy in Glioblastoma?

Peter Hau,1 Roger Stupp,2 and Monika E. Hegi3

1Klinikum der Universität Regensburg, Klinik und Poliklinik für Neurologie am Bezirksklinikum, 93053 Regensburg, Germany
2Multidisciplinary Oncology Center, University Hospital Lausanne (CHUV), 1011 Lausanne, Switzerland
3Laboratory of Tumor Biology and Genetics Department of Neurosurgery, University Hospital Lausanne (CHUV), 1011 Lausanne, and National Center of Competence in Research (NCCR) Molecular Oncology, Swiss Institute for Cancer Research (ISREC), Switzerland

Received 18 January 2007; Accepted 18 January 2007

Copyright © 2007 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Peter Hau, Roger Stupp, and Monika E. Hegi, “MGMT Methylation Status: The Advent of Stratified Therapy in Glioblastoma?,” Disease Markers, vol. 23, no. 1-2, pp. 97-104, 2007. https://doi.org/10.1155/2007/159242.